Kalaris Therapeutics Inc
KLRS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$11,894 | -$11,350 | -$10,196 | – |
| Dep. & Amort. | $0 | $0 | $0 | – |
| Deferred Tax | $0 | $0 | $0 | – |
| Stock-Based Comp. | $0 | $0 | $374 | – |
| Change in WC | -$9 | -$1,780 | $2,346 | – |
| Other Non-Cash | $570 | -$1,755 | $35 | – |
| Operating Cash Flow | -$11,333 | -$14,885 | -$7,441 | – |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$183 | $0 | $0 | – |
| Net Acquisitions | $0 | $0 | $0 | – |
| Inv. Purchases | -$34,523 | $0 | $0 | – |
| Inv. Sales/Matur. | $0 | $0 | $0 | – |
| Other Inv. Act. | $0 | $0 | $0 | – |
| Investing Cash Flow | -$34,706 | $0 | $0 | – |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $7,500 | $7,500 | – |
| Stock Issued | $0 | $0 | $0 | – |
| Stock Repurch. | $0 | $0 | $0 | – |
| Dividends Paid | $0 | $0 | $0 | – |
| Other Fin. Act. | $0 | -$5,154 | $99,767 | – |
| Financing Cash Flow | $0 | $2,346 | $107,267 | – |
| Forex Effect | $0 | $0 | $0 | – |
| Net Chg. in Cash | -$46,039 | -$12,539 | $99,826 | – |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $88,426 | $100,965 | $1,639 | – |
| End Cash | $42,387 | $88,426 | $101,465 | – |
| Free Cash Flow | -$11,516 | -$14,885 | -$7,441 | – |